These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25975189)

  • 41. Influence of somatic mutations and pretransplant strategies in patients allografted for myelodysplastic syndrome or secondary acute myeloid leukemia.
    Rautenberg C; Germing U; Stepanow S; Lauseker M; Köhrer K; Jäger PS; Geyh S; Fan M; Haas R; Kobbe G; Schroeder T
    Am J Hematol; 2021 Jan; 96(1):E15-E17. PubMed ID: 33017477
    [No Abstract]   [Full Text] [Related]  

  • 42. Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia.
    Yoshimi A; Strahm B; Baumann I; Furlan I; Schwarz S; Teigler-Schlegel A; Walther JU; Schlegelberger B; Göhring G; Nöllke P; Führer M; Niemeyer CM
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):425-9. PubMed ID: 24316460
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A fatal Clostridium infection in an allogeneic stem cell transplant recipient.
    Jain M; Titanji R; Rapoport AP; Wang W; Gocke C; Cross A; Akpek G
    Bone Marrow Transplant; 2005 Sep; 36(5):455-7. PubMed ID: 15995716
    [No Abstract]   [Full Text] [Related]  

  • 44. Acute myeloid leukaemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Ferretti G; Papaldo P
    Breast Cancer Res Treat; 2008 May; 109(1):187-8. PubMed ID: 17616805
    [No Abstract]   [Full Text] [Related]  

  • 45. The heterogeneity of leukemia occurring after treatment for sarcoma.
    Varterasian M; Zalupski M; Karanes C
    Am J Clin Oncol; 1997 Dec; 20(6):585-6. PubMed ID: 9391546
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characteristics and Outcomes of Second Malignant Neoplasms after Childhood Cancer Treatment: Multi-Center Retrospective Survey.
    Koh KN; Yoo KH; Im HJ; Sung KW; Koo HH; Kim HS; Han JW; Yoon JH; Park HJ; Park BK; Baek HJ; Kook H; Lee JA; Lee JM; Lee KC; Kim SK; Park M; Lee YH; Lyu CJ; Seo JJ
    J Korean Med Sci; 2016 Aug; 31(8):1254-61. PubMed ID: 27478336
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute myeloid leukemia. Introduction.
    Bloomfield CD; Marcucci G; Döhner K; Döhner H
    Semin Oncol; 2008 Aug; 35(4):324-5. PubMed ID: 18692682
    [No Abstract]   [Full Text] [Related]  

  • 48. Role of minimal residual disease and chimerism after reduced-intensity and myeloablative allo-transplantation in acute myeloid leukemia and high-risk myelodysplastic syndrome.
    Bernal T; Diez-Campelo M; Godoy V; Rojas S; Colado E; Alcoceba M; González M; Vidriales B; Sánchez-Guijo FM; López-Corral L; Luño E; del Cañizo C
    Leuk Res; 2014 May; 38(5):551-6. PubMed ID: 24655806
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Time-dependent effects of clinical predictors in unrelated hematopoietic stem cell transplantation.
    Fuerst D; Mueller C; Beelen DW; Neuchel C; Tsamadou C; Schrezenmeier H; Mytilineos J
    Haematologica; 2016 Feb; 101(2):241-7. PubMed ID: 26611475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognosis of secondary acute myeloid leukemia is affected by the type of the preceding hematologic disorders and the presence of trisomy 8.
    Koh Y; Kim I; Bae JY; Song EY; Kim HK; Yoon SS; Lee DS; Park SS; Park MH; Park S; Kim BK
    Jpn J Clin Oncol; 2010 Nov; 40(11):1037-45. PubMed ID: 20587614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Development of acute myeloid leukemia in a myelodysplastic syndrome patient after allogeneic hematopoietic stem cell transplantation for 12 years: a case report and literature review].
    Li Z; Zhang Y; Zhou J; Fang B; Lin Q; Song Y
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jan; 35(1):63-5. PubMed ID: 24602738
    [No Abstract]   [Full Text] [Related]  

  • 52. Treatment of therapy-related leukemia and myelodysplastic syndrome.
    Kantarjian HM; Estey EH; Keating MJ
    Hematol Oncol Clin North Am; 1993 Feb; 7(1):81-107. PubMed ID: 7680643
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes of patients with therapy-related AML/myelodysplastic syndrome (t-AML/MDS) following hematopoietic cell transplantation.
    Alam N; Atenafu EG; Kuruvilla J; Uhm J; Lipton JH; Messner HA; Kim DH; Seftel M; Gupta V
    Bone Marrow Transplant; 2015 Sep; 50(9):1180-6. PubMed ID: 26121109
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Can allogeneic hematopoietic cell transplant cure therapy-related acute leukemia?
    Madanat YF; Gerds AT
    Best Pract Res Clin Haematol; 2019 Mar; 32(1):104-113. PubMed ID: 30927969
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ABO blood group incompatibility as an adverse risk factor for outcomes in patients with myelodysplastic syndromes and acute myeloid leukemia undergoing HLA-matched peripheral blood hematopoietic cell transplantation after reduced-intensity conditioning.
    Hefazi M; Litzow M; Hogan W; Gastineau D; Jacob E; Damlaj M; Hashmi S; Al-Kali A; Patnaik MM
    Transfusion; 2016 Feb; 56(2):518-27. PubMed ID: 26446051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes.
    Lee HC; Saliba RM; Rondon G; Chen J; Charafeddine Y; Medeiros LJ; Alatrash G; Andersson BS; Popat U; Kebriaei P; Ciurea S; Oran B; Shpall E; Champlin R
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1948-54. PubMed ID: 26183077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy.
    Carney DA; Westerman DA; Tam CS; Milner A; Prince HM; Kenealy M; Wolf M; Januszewicz EH; Ritchie D; Came N; Seymour JF
    Leukemia; 2010 Dec; 24(12):2056-62. PubMed ID: 20962860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myelodysplastic syndrome following chemoradiotherapy for carcinoma breast and Wilm's tumour.
    Varma S; Varma N; Sharma BK
    Indian J Cancer; 1992 Sep; 29(3):136-8. PubMed ID: 1338057
    [No Abstract]   [Full Text] [Related]  

  • 59. Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis.
    Forrest DL; Nevill TJ; Naiman SC; Le A; Brockington DA; Barnett MJ; Lavoie JC; Nantel SH; Song KW; Shepherd JD; Sutherland HJ; Toze CL; Davis JH; Hogge DE
    Bone Marrow Transplant; 2003 Nov; 32(9):915-23. PubMed ID: 14561993
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comorbidity predicts survival in myelodysplastic syndromes or secondary acute myeloid leukaemia after allogeneic stem cell transplantation.
    Boehm A; Sperr WR; Leitner G; Worel N; Oehler L; Jaeger E; Mitterbauer M; Haas OA; Valent P; Kalhs P; Rabitsch W
    Eur J Clin Invest; 2008 Dec; 38(12):945-52. PubMed ID: 19021720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.